Ketamine therapy has become known for its effects at combating depression and other mood disorders. There’s a growing body of ...

Researchers at the University of Virginia Brain Institute and UVA School of Medicine will conduct a trial to see if the ...

The University of Virginia (UVA) is spearheading a nationwide clinical trial exploring a new treatment option for prolonged ...

Johnson & Johnson's ketamine-derived nasal spray has been approved as a standalone treatment to fight depression for those ...

Respondents who said they used other drugs recreationally were also likelier to say they used ketamine during the past year ...

The U.S. Food and Drug Administration expanded approval for Johnson & Johnson’s nasal spray, Spravato, to allow it to be used ...

Exploring new treatment avenues has become crucial as mental health challenges such as depression and PTSD continue impacting ...

A multidisciplinary approach, including ketamine withdrawal and symptom management, is essential to mitigate long-term ...

Because it is still awaiting approval, Medicare does not typically cover the use of ketamine infusion for treating mental ...